Dark

Check out our Dark Pool Levels

CVLBD
Conversion Labs, Inc. Common Stock
stock OTC

No price data

0.00USD0.000%(0.00)0

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewExchangesShortsNews

Dec 9, 2020

08:31AM EST Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital Market. The companys common stock will commence trading on the exchange at the opening of the market tomorrow, December 10, 2020, under the same symbol, CVLB. GlobeNewswire Inc

Nov 20, 2020

07:31AM EST Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed expert Life Sciences attorney, Eric H. Yecies, to the new position of chief compliance officer and general counsel. GlobeNewswire Inc

Nov 16, 2020

04:01PM EST Conversion Labs Q3 2020 Revenue up 252% to Record $11.0 Million GlobeNewswire Inc

Nov 10, 2020

07:31AM EST Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has appointed Roberto Simon to its board of directors and as the chair of its audit committee. Following his appointment, the board now has eight members, with six serving as independent directors. GlobeNewswire Inc

Nov 9, 2020

01:00PM EST Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. The financial results will be issued in a press release prior to the call. GlobeNewswire Inc

Nov 4, 2020

09:00AM EST Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 million of a $15 million private placement with institutional investors at a purchase price of $4.75 per share. A second closing of an additional $500,000 is expected within the next seven days. GlobeNewswire Inc

Oct 26, 2020

03:22PM EDT How Conversion Labs Is Building Its Telemedicine Business During COVID-19 Benzinga

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with Restorsea, a leading medical grade skincare technology platform. GlobeNewswire Inc

Oct 14, 2020

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will effect a 1-for-5 reverse split of its common stock effective prior to the opening of the market today, Wednesday, October 14, 2020. GlobeNewswire Inc

Share